col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

97 Results       Page 1

Springer Science and Business Media LLC: Nature Biotechnology
  original article Date Title Authors   All Authors
1 [GO] 2023―Apr―24 A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines Aurélien vander Straeten, Morteza Sarmadi, John L. Daristotle, Maria Kanelli, Lisa H. Tostanoski, Joe Collins, et al. (+20)
2 [GO] 2023―Apr―17 Long COVID immune phenotypes identified for blockade Jared B. Fudge
3 [GO] 2022―Nov―02 The Coronavirus Standards Working Group’s roadmap for improved population testing Tim Mercer, Neil Almond, Michael A. Crone, Patrick S. G. Chain, Alina Deshpande, Deepa Eveleigh, et al. (+21)
4 [GO] 2022―Oct―10 A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets Yadi Zhou, Yuan Liu, Shagun Gupta, Mauricio I. Paramo, Yuan Hou, Chengsheng Mao, et al. (+17)
5 [GO] 2022―Oct―10 A proteome-scale map of the SARS-CoV-2-human contactome Dae-Kyum Kim, Benjamin Weller, Chung-Wen Lin, Dayag Sheykhkarimli, Jennifer J. Knapp, Guillaume Dugied, et al. (+46)
6 [GO] 2022―Oct―07 What the COVID-19 pandemic revealed about intellectual property E. Richard Gold
7 [GO] 2022―Jul―21 The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants Sylvia Rothenberger, Daniel L. Hurdiss, Marcel Walser, Francesca Malvezzi, Jennifer Mayor, Sarah Ryter, et al. (+62)
8 [GO] 2022―Jul―21 Wastewater is a robust proxy for monitoring circulating SARS-CoV-2 variants
9 [GO] 2022―Jul―18 Author Correction: LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding Kerstin U. Ludwig, Ricarda M. Schmithausen, David Li, Max L. Jacobs, Ronja Hollstein, Katja Blumenstock, et al. (+34)
10 [GO] 2022―Jul―18 Viral variant-resolved wastewater surveillance of SARS-CoV-2 at national scale Fabian Amman, Rudolf Markt, Lukas Endler, Sebastian Hupfauf, Benedikt Agerer, Anna Schedl, et al. (+33)
11 [GO] 2022―Jul―13 The COVID-19 vaccine patent race Ulrich Storz
12 [GO] 2022―Jun―20 Smartphone apps in the COVID-19 pandemic Jay A. Pandit, Jennifer M. Radin, Giorgio Quer, Eric J. Topol
13 [GO] 2022―Jun―17 Measuring SARS-CoV-2 T cell immunity with a scalable qPCR-based assay
14 [GO] 2022―Jun―15 A virtual innovation bootcamp to remotely connect and empower students to solve COVID-19-related medical problems Mario V. Russo, Abhinav J. Appukutty, Aadit P. Shah, Harsha K. Mohan, Andy G. S. Daniel, Andrew Pack, Richard Xie
15 [GO] 2022―Jun―13 Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR Megan Schwarz, Denis Torre, Daniel Lozano-Ojalvo, Anthony T. Tan, Tommaso Tabaglio, Slim Mzoughi, et al. (+48)
16 [GO] 2022―Apr―28 Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants Jason Z. Zhang, Hsien-Wei Yeh, Alexandra C. Walls, Basile I. M. Wicky, Kaitlin R. Sprouse, Laura A. VanBlargan, et al. (+18)
17 [GO] 2022―Mar―16 DARPins score against COVID-19
18 [GO] 2022―Mar―16 Contractual solutions to overcome drug scarcity during pandemics and epidemics Sapna Kumar, Ana Santos Rutschman
19 [GO] 2022―Mar―03 Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking Andrea R. Shiakolas, Kevin J. Kramer, Nicole V. Johnson, Steven C. Wall, Naveenchandra Suryadevara, Daniel Wrapp, et al. (+12)
20 [GO] 2022―Feb―28 Multiscale PHATE identifies multimodal signatures of COVID-19 Manik Kuchroo, Jessie Huang, Patrick Wong, Jean-Christophe Grenier, Dennis Shung, Alexander Tong, et al. (+102)
21 [GO] 2022―Jan―20 African coronavirus surveillance network provides early warning for world Paul Adepoju
22 [GO] 2022―Jan―19 COVID-19 vaccine makers chase variant-ready vaccines Cormac Sheridan
23 [GO] 2021―Dec―20 Single-cell immunology of SARS-CoV-2 infection Yuan Tian, Lindsay N. Carpp, Helen E. R. Miller, Michael Zager, Evan W. Newell, Raphael Gottardo
24 [GO] 2021―Dec―17 A humanized mouse model of chronic COVID-19 Esen Sefik, Benjamin Israelow, Haris Mirza, Jun Zhao, Rihao Qu, Eleanna Kaffe, et al. (+8)
25 [GO] 2021―Dec―06 Technologies to advance COVID-19 vaccine equity
26 [GO] 2021―Nov―25 COVID-19 antiviral pills raise hopes for curbing pandemic Charlotte Harrison
27 [GO] 2021―Nov―16 First COVID-19 DNA vaccine approved, others in hot pursuit Cormac Sheridan
28 [GO] 2021―Oct―07 Nanotechnology offers alternative ways to fight COVID-19 pandemic with antivirals Mark Peplow
29 [GO] 2021―Sep―29 Ready-to-use public infrastructure for global SARS-CoV-2 monitoring Wolfgang Maier, Simon Bray, Marius van den Beek, Dave Bouvier, Nathan Coraor, Milad Miladi, et al. (+11)
30 [GO] 2021―Sep―28 A public-private partnership model for COVID-19 diagnostics Peter H. L. Krijger, Tim A. Hoek, Sanne Boersma, Lieke I. P. M. Donders, Maaike M. C. Broeders, Mark Pieterse, et al. (+19)
31 [GO] 2021―Sep―06 Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19 Jihoon W. Lee, Yapeng Su, Priyanka Baloni, Daniel Chen, Ana Jimena Pavlovitch-Bedzyk, Dan Yuan, et al. (+18)
32 [GO] 2021―Aug―18 Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children J. Loske, J. Röhmel, S. Lukassen, S. Stricker, V. G. Magalhães, J. Liebig, et al. (+17)
33 [GO] 2021―Aug―10 The lag in SARS-CoV-2 genome submissions to GISAID Kishan Kalia, Gayatri Saberwal, Gaurav Sharma
34 [GO] 2021―Jul―26 Publisher Correction: COVID-19 long haulers Charles Schmidt
35 [GO] 2021―Jul―13 COVID-19 long haulers Charles Schmidt
36 [GO] 2021―Jul―13 Malaria vaccine wows and seeds COVID-19 vaccine effort Heidi Ledford
37 [GO] 2021―Jun―29 Publisher Correction: ‘Super-antibodies’ could curb COVID-19 and help avert future pandemics Elie Dolgin
38 [GO] 2021―Jun―29 LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding Kerstin U. Ludwig, Ricarda M. Schmithausen, David Li, Max L. Jacobs, Ronja Hollstein, Katja Blumenstock, et al. (+33)
39 [GO] 2021―Jun―22 ‘Super-antibodies’ could curb COVID-19 and help avert future pandemics Elie Dolgin
40 [GO] 2021―May―24 The need for global access to biomedical innovations during pandemics Rajesh Gupta
41 [GO] 2021―May―12 What two US counties will tell us about COVID-19
42 [GO] 2021―May―12 A network analysis of COVID-19 mRNA vaccine patents Mario Gaviria, Burcu Kilic
43 [GO] 2021―May―12 COVID-19 testing turns to T cells Cormac Sheridan
44 [GO] 2021―Apr―12 Waive COVID-19 IP rights, poor nations urge
45 [GO] 2021―Mar―25 Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection Susanna K. Elledge, Xin X. Zhou, James R. Byrnes, Alexander J. Martinko, Irene Lui, Katarina Pance, et al. (+13)
46 [GO] 2021―Mar―10 European Patent Office grants controversial patent protecting virus: lessons from the Middle East respiratory syndrome coronavirus outbreak Carsten D. Richter
47 [GO] 2021―Feb―23 Biological activity-based modeling identifies antiviral leads against SARS-CoV-2 Ruili Huang, Miao Xu, Hu Zhu, Catherine Z. Chen, Wei Zhu, Emily M. Lee, et al. (+14)
48 [GO] 2021―Feb―22 Mapping innovation trajectories on SARS-CoV-2 and its variants Osmat Azzam Jefferson, Deniz Koellhofer, Ben Warren, Thomas Ehrich, Simon Lang, Kenny Williams, et al. (+4)
49 [GO] 2021―Feb―20 Could mutations of SARS-CoV-2 suppress diagnostic detection? Carl A. Ascoli
50 [GO] 2021―Feb―06 Balancing clinical evidence in the context of a pandemic Jacob J. Adashek, Razelle Kurzrock
51 [GO] 2021―Feb―03 Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents Emmeline L. Blanchard, Daryll Vanover, Swapnil Subhash Bawage, Pooja Munnilal Tiwari, Laura Rotolo, Jared Beyersdorf, et al. (+13)
52 [GO] 2021―Jan―18 Research priorities for COVID-19 sensor technology Allison Tong, Tania C. Sorrell, Andrew J. Black, Corinne Caillaud, Wojciech Chrzanowski, Eugena Li, et al. (+8)
53 [GO] 2021―Jan―11 Hunt for improved monoclonals against coronavirus gathers pace Ken Garber
54 [GO] 2021―Jan―11 AstraZeneca joins Russia to boost coronavirus vaccine
55 [GO] 2021―Jan―08 Publisher Correction: COVID-19 antibodies on trial Laura DeFrancesco
56 [GO] 2020―Dec―24 Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19 Saskia Trump, Soeren Lukassen, Markus S. Anker, Robert Lorenz Chua, Johannes Liebig, Loreen Thürmann, et al. (+32)
57 [GO] 2020―Nov―25 COVID-19 vaccines poised for launch, but impact on pandemic unclear Elie Dolgin
58 [GO] 2020―Nov―05 Coronavirus testing finally gathers speed Cormac Sheridan
59 [GO] 2020―Oct―21 COVID-19 antibodies on trial Laura DeFrancesco
60 [GO] 2020―Oct―05 Pledging intellectual property for COVID-19 Jorge L. Contreras, Michael Eisen, Ariel Ganz, Mark Lemley, Jenny Molloy, Diane M. Peters, Frank Tietze
61 [GO] 2020―Sep―28 Whither COVID-19 vaccines? Laura DeFrancesco
62 [GO] 2020―Sep―21 Tracking COVID-19 with wastewater David A. Larsen, Krista R. Wigginton
63 [GO] 2020―Sep―18 Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics Jordan Peccia, Alessandro Zulli, Doug E. Brackney, Nathan D. Grubaugh, Edward H. Kaplan, Arnau Casanovas-Massana, et al. (+8)
64 [GO] 2020―Sep―17 Author Correction: Detection of SARS-CoV-2 in nasal swabs using MALDI-MS Fabiane M. Nachtigall, Alfredo Pereira, Oleksandra S. Trofymchuk, Leonardo S. Santos
65 [GO] 2020―Sep―04 Massive data initiatives and AI provide testbed for pandemic forecasting Cormac Sheridan
66 [GO] 2020―Aug―27 Evaluation of SARS-CoV-2 serology assays reveals a range of test performance Jeffrey D. Whitman, Joseph Hiatt, Cody T. Mowery, Brian R. Shy, Ruby Yu, Tori N. Yamamoto, et al. (+66)
67 [GO] 2020―Aug―20 The COVID-19 XPRIZE and the need for scalable, fast, and widespread testing Matthew J. MacKay, Anna C. Hooker, Ebrahim Afshinnekoo, Marc Salit, Jason Kelly, Jonathan V. Feldstein, et al. (+14)
68 [GO] 2020―Aug―11 A singular view of COVID-19 Michael Eisenstein
69 [GO] 2020―Aug―06 Agtech infrastructure for pandemic preparedness Steven R. Webb, Richard M. Twyman, Maurice Moloney
70 [GO] 2020―Aug―05 Focus shifts to antibody cocktails for COVID-19 cytokine storm Charlotte Harrison
71 [GO] 2020―Jul―30 Detection of SARS-CoV-2 in nasal swabs using MALDI-MS Fabiane M. Nachtigall, Alfredo Pereira, Oleksandra S. Trofymchuk, Leonardo S. Santos
72 [GO] 2020―Jul―23 A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction Chee Wah Tan, Wan Ni Chia, Xijian Qin, Pei Liu, Mark I.-C. Chen, Charles Tiu, et al. (+10)
73 [GO] 2020―Jul―23 Pandemic preparedness in Taiwan Wei-Kai Wu, Jyh-Ming Liou, Cheng-Chih Hsu, Yung-Hsiang Lin, Ming-Shiang Wu
74 [GO] 2020―Jul―17 Author Correction: Scalable and robust SARS-CoV-2 testing in an academic center Jim Aitken, Karen Ambrose, Sam Barrell, Rupert Beale, Ganka Bineva-Todd, Dhruva Biswas, et al. (+74)
75 [GO] 2020―Jul―08 First NGS-based COVID-19 diagnostic
76 [GO] 2020―Jul―08 A COVID-19 model
77 [GO] 2020―Jul―08 COVID-19 spurs wave of innovative diagnostics Cormac Sheridan
78 [GO] 2020―Jun―26 COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis Robert Lorenz Chua, Soeren Lukassen, Saskia Trump, Bianca P. Hennig, Daniel Wendisch, Fabian Pott, et al. (+30)
79 [GO] 2020―Jun―18 Scalable and robust SARS-CoV-2 testing in an academic center
80 [GO] 2020―Jun―18 Blueprint for a pop-up SARS-CoV-2 testing lab
81 [GO] 2020―Jun―09 Genomic search for COVID-19 severity clues
82 [GO] 2020―Jun―09 Coronaviruses
83 [GO] 2020―Jun―05 Coronavirus vaccine developers wary of errant antibodies Ken Garber
84 [GO] 2020―Jun―05 Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures Nikolai Eroshenko, Taylor Gill, Marianna K. Keaveney, George M. Church, Jose M. Trevejo, Hannu Rajaniemi
85 [GO] 2020―Jun―03 The COVID-19 testing debacle
86 [GO] 2020―May―29 Questions remain following first COVID-19 vaccine results Cormac Sheridan
87 [GO] 2020―May―22 Diagnostics and the coronavirus: don’t let the standards slip Mark Page, Neil Almond, Nicola J. Rose, Christian K. Schneider
88 [GO] 2020―May―16 Drug researchers pursue new lines of attack against COVID-19 Charlotte Harrison
89 [GO] 2020―May―15 Biotech companies prepare for COVID-19 downturn Melanie Senior
90 [GO] 2020―May―11 Biggest COVID-19 trial tests repurposed drugs first
91 [GO] 2020―May―01 Convalescent serum lines up as first-choice treatment for coronavirus Cormac Sheridan
92 [GO] 2020―Apr―21 Developing therapeutic monoclonal antibodies at pandemic pace Brian Kelley
93 [GO] 2020―Apr―16 CRISPR-Cas12-based detection of SARS-CoV-2 James P. Broughton, Xianding Deng, Guixia Yu, Clare L. Fasching, Venice Servellita, Jasmeet Singh, et al. (+14)
94 [GO] 2020―Mar―23 Fast, portable tests come online to curb coronavirus pandemic Cormac Sheridan
95 [GO] 2020―Mar―20 The pandemic pipeline John Hodgson
96 [GO] 2020―Feb―27 Coronavirus puts drug repurposing on the fast track Charlotte Harrison
97 [GO] 2020―Feb―19 Coronavirus and the race to distribute reliable diagnostics Cormac Sheridan

97 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec